Emulsions are widely used as topical formulations in the pharmaceutical and cosmetic industry. They are thermodynamically unstable and require emulsifiers to stabilize them physically. A literature survey has revealed that emulsifiers could have an effect on topical delivery. Therefore, the overall aim of this research project was to investigate and to understand the various effects of biopolymers, chosen for this study as emulsifiers, on the release and the topical delivery of an active ingredient from emulsion-based delivery systems. Emulsions were stabilized by either whey protein alone or in combination with chitosan or carrageenan. Salicylic acid was chosen as a model drug. Furthermore, the emulsions were prepared at three different pH values (pH 4, 5 and 6) in order to introduce different charges to the polymeric emulsifiers and subsequently determine the effect of pH on release as well as on dermal and transdermal delivery. Emulsion characteristics, such as droplet size, zeta potential, viscosity and stability against creaming and coalescence were ascertained. In addition, turbidity was determined to evaluate the degree of insoluble complex formation in the aqueous phase of the emulsions. A high pressure liquid chromatographic (HPLC) method was validated for the quantitative determination of salicylic acid in the release, skin and transdermal perfusate samples. Nine emulsions were formulated, utilizing the layer-by-layer (LbL) self-assembly technique, from which the release of salicylic acid was determined. These release studies were conducted, utilizing nitrocellulose membranes (0.2 μm pore size) with the use of Franz-type diffusion cells in four replicates per formulation over a time period of 8 hours. Based on the emulsion characterization and release data, six formulations, including the oil solution, were chosen to determine dermal and transdermal delivery of salicylic acid. During the diffusion studies, the effect of different pH (whey protein pH 4.00, 5.00 and 6.00), different polymers and different polymer combinations were investigated. These diffusion studies were conducted with the use of dermatomed (thickness ~400 μm), human abdominal skin and Franz-type diffusion cells over a period of 24 hours. The characterization of the emulsions revealed no significant differences in the droplet size and viscosity between the various formulations. All emulsions showed stability towards coalescence over a time period of 7 days; however, not all the emulsions showed stability towards creaming and flocculation. The results of the release studies indicated that an increase in emulsion droplet charge could have a negative effect on the release of salicylic acid from these formulations. In contrast, positively charged emulsion droplets could enhance the dermal and transdermal delivery of salicylic acid from emulsions. It was hypothesized that electrostatic complex formation between the emulsifier and salicylic acid could affect the release, whereas electrostatic interaction between emulsion droplets and skin could influence dermal/transdermal delivery of the active. Furthermore, the degree of ionization of salicylic acid played an important role in the dermal and transdermal delivery of salicylic acid from the various emulsions. / MSc (Pharmaceutics), North-West University, Potchefstroom Campus, 2014

Emulsions are widely used as topical formulations in the pharmaceutical and cosmetic industry. They are thermodynamically unstable and require emulsifiers to stabilize them physically. A literature survey has revealed that emulsifiers could have an effect on topical delivery. Therefore, the overall aim of this research project was to investigate and to understand the various effects of biopolymers, chosen for this study as emulsifiers, on the release and the topical delivery of an active ingredient from emulsion-based delivery systems. Emulsions were stabilized by either whey protein alone or in combination with chitosan or carrageenan. Salicylic acid was chosen as a model drug. Furthermore, the emulsions were prepared at three different pH values (pH 4, 5 and 6) in order to introduce different charges to the polymeric emulsifiers and subsequently determine the effect of pH on release as well as on dermal and transdermal delivery. Emulsion characteristics, such as droplet size, zeta potential, viscosity and stability against creaming and coalescence were ascertained. In addition, turbidity was determined to evaluate the degree of insoluble complex formation in the aqueous phase of the emulsions. A high pressure liquid chromatographic (HPLC) method was validated for the quantitative determination of salicylic acid in the release, skin and transdermal perfusate samples. Nine emulsions were formulated, utilizing the layer-by-layer (LbL) self-assembly technique, from which the release of salicylic acid was determined. These release studies were conducted, utilizing nitrocellulose membranes (0.2 μm pore size) with the use of Franz-type diffusion cells in four replicates per formulation over a time period of 8 hours. Based on the emulsion characterization and release data, six formulations, including the oil solution, were chosen to determine dermal and transdermal delivery of salicylic acid. During the diffusion studies, the effect of different pH (whey protein pH 4.00, 5.00 and 6.00), different polymers and different polymer combinations were investigated. These diffusion studies were conducted with the use of dermatomed (thickness ~400 μm), human abdominal skin and Franz-type diffusion cells over a period of 24 hours. The characterization of the emulsions revealed no significant differences in the droplet size and viscosity between the various formulations. All emulsions showed stability towards coalescence over a time period of 7 days; however, not all the emulsions showed stability towards creaming and flocculation. The results of the release studies indicated that an increase in emulsion droplet charge could have a negative effect on the release of salicylic acid from these formulations. In contrast, positively charged emulsion droplets could enhance the dermal and transdermal delivery of salicylic acid from emulsions. It was hypothesized that electrostatic complex formation between the emulsifier and salicylic acid could affect the release, whereas electrostatic interaction between emulsion droplets and skin could influence dermal/transdermal delivery of the active. Furthermore, the degree of ionization of salicylic acid played an important role in the dermal and transdermal delivery of salicylic acid from the various emulsions. / MSc (Pharmaceutics), North-West University, Potchefstroom Campus, 2014